Introducing BCM-MitomeNGSSM Retinitis Pigmentosa Panel
The Medical Genetics Laboratories (MGL) at Baylor College of Medicine has been providing the medical genetics community with high quality comprehensive diagnostic services for over 40 years. By building on our institution’s strengths in research and discovery, we are committed to providing quality genetic testing services relevant to twenty-first century medicine. Working in close collaboration with clinical experts such as professors, Arthur Beaudet, M.D. and Richard Lewis M.D., M.S., MGL has developed comprehensive molecular testing for Retinitis Pigmentosa and allied retinal dystrophies. The BCM-MitomeNGSSM Retinitis Pigmentosa panel evaluates 66 genes and has been clinically validated using Next Generation Sequencing technology to ensure 100% coverage of the coding region of each gene. This assay is designed to detect small deletions/duplications as well as single nucleotide changes in the targeted 66 genes.
Three reasons to use BCM’s Medical Genetics Laboratories for your complex testing needs:
- On time delivery of test results. In the last six months, 99% of the BCM-MitomeNGSSM tests were reported out on time.
- Lower cost and time to diagnosis with pathway-driven gene panels.
- Industry-leading professionals in clinical and diagnostic interpretation.
For more information on ordering this panel, please email email@example.com
or call 1-800-411-GENE (4363).